HELIX3
INC.
Comet Assay News
Latest News
Copyright© 2003-2012 Helix3 Inc. All Rights Reserved


Dec 2011: Helix3 develops their acellular comet assay protocol to provide test compound DNA reactivity data for screening and/or for mode of action determination
Nov 2011: The ICH Steering committee approves the revised ICH S2(R1) Guideline on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
Oct 2010: Helix3 presents Regulatory Safety Testing with the In Vivo Comet Assay: Recommendations for Data Interpretation
Dec 2009: To address the new ICH S2(R1) Guidelines, recommendations for conducting combined in vivo comet and micronucleus assays and addressing cytotoxicity is published by Helix3 in Mutagenesis.
Sep 2009: Genotoxicity testing using the Acellular comet assay developed at Helix3 to minimize false positive in vitro test results.
Aug 2009: 5th International Workgroup on Genotoxicity Tests (IWGT) Meets in Basal Switzerland to Discuss Recommendations for ICH Guideline Revisions.
Jan 2009: Germ cell genotoxicity testing recommended for product safety.
Oct 2008: The European Food Safety Authority (EFSA) recommends the use of the in vivo comet assay as a follow up to an in vitro positive.
Mar 2008: ICH Guidelines for Genotoxicity Testing modified to include the comet assay in the target organ(s).
Jun 2007: The new chemicals legislation REACH (Registration, Evaluation, Authorisation, and Resriction of Chemicals) enters into force requiring additional testing to improve safety.
Mar 2007: ECVAM Workshop convenes to discuss methods for reducing false positive in vitro results
Important Publications